Triple Inhaled Therapy in COPD: Current Guidelines, Benefits/Risks, and ETHOS Trial Discussion

Password

Forgot your password?

Select specialty

First name

Last name

Choose Password

Playback speed

10 seconds

By National Jewish Health FEATURING James P. Woodrow

0 views

August 12, 2021

James Woodrow, MD, of National Jewish Health, discusses the article “Triple Inhaled Therapy at Two ...
read more ↘ Glucocorticoid Doses in Moderate to Very Severe COPD” during the 30-minute inaugural webinar of the COPD Journal Club on August 3, 2021.

View the Article Summary:

Triple Inhaled Therapy at Two Glucocorticoid Doses in Moderate to Very Severe COPD (ETHOS Trial) N England J Med 2020; 383:35-48.

https://www.nationaljewish.org/education/pro-ed/live-events/national-jewish-health-journal-clubs/pdfs/copd-article-summary-triple-therapy_vol1_issue1.aspx
↖ read less

Comments 1